Journal
INTERNATIONAL JOURNAL OF TOXICOLOGY
Volume 28, Issue 6, Pages 498-509Publisher
SAGE PUBLICATIONS INC
DOI: 10.1177/1091581809348718
Keywords
acute central nervous system effects; cross-species extrapolations; cyclohexane; physiologically based pharmacokinetic models; occupational exposure limits; solvent neurotoxicity toxicokinetics
Categories
Funding
- CEFIC Hydrocarbon Solvent Producers Association
- Netherlands Ministry of Economic Affairs
Ask authors/readers for more resources
This report describes a physiologically based pharmacokinetic model for cyclohexane and its use in comparing internal doses in rats and volunteers following inhalation exposures. Parameters describing saturable metabolism of cyclohexane are measured in rats and used along with experimentally determined partition coefficients. The model is evaluated by comparing predicted blood and brain concentrations to data from studies in rats and then allometrically scaling the results to humans. Levels of cyclohexane in blood and exhaled air are measured in human volunteers and compared with model values. The model predicts that exposure of volunteers to cyclohexane at levels of 4100 mg/m(3) (similar to 1200 ppm) will result in brain levels similar to those in rats exposed to 8000 mg/m(3) ( the no-effect level for acute central nervous system effects). There are no acute central nervous system effects in humans exposed to 860 mg/m(3), consistent with model predictions that current occupational exposure levels for cyclohexane protect against acute central nervous system effects.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available